NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|998614169|ref|NP_001307259|]
View 

phosphate-regulating neutral endopeptidase PHEX isoform 1 [Danio rerio]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
72-736 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 748.43  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  72 VDPCDDFYQYACGGWLRENPIPEDSSSYGIYPWLRQNVDLKLKELLEQPVRSG-DIEAVKKAKVLYASCMNESALEIEDA 150
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAaDSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 151 NPLLKNLKQKEfRWPVLGDalgsssrwvesqfNLLETLAQIRSQHSKSVLIRLFVAPDDKNSNQYIIKLDQASLSLSSRE 230
Cdd:cd08662   81 KPLKPLLDKIG-GLPSLDD-------------LAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRD 146
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 231 DYitNTTEAQMYREALLRLMVDVSVMLGASEQAAEAQMKSVLDFEMKLAQIVIP-YENRTSENMYNKYSLSKLQRTVPDF 309
Cdd:cd08662  147 YY--LDEENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSsEELRDPEKTYNPLTLAELQKLAPSI 224
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 310 NWLGFVRAVIDTElypdlkiSSSEQVIVRAPQYFKDLFKLINATDTRTVANYVIWRSVFSRITTLSRRFLYRYLDFARVT 389
Cdd:cd08662  225 DWKAYLKALGPPA-------DDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKAL 297
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 390 TGTTSLTPRWDKCVNYVENTLIYAAGRLFVDKHFQEDKKHMMEELINGIRWAFIDILEkENEWMDEETKRKAIDKAHAVL 469
Cdd:cd08662  298 SGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLE-NLDWMDEETKKKALEKLDAMK 376
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 470 PKVGYPDFILNDTYINEDIKRLAFTmTDYFGNVMQTLKFIAQSDIGWLRKTVPRTEWFTNPTTVNAFYSSSTNQIRFPAG 549
Cdd:cd08662  377 VKIGYPDKWRDYSALDIYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAG 455
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 550 ELQKPFFwGLNYPRSLSYGAIGVIVGHELTHGFDNNGRKYDKDGNLDQWWSNSSINRFTEKTQCMIDQYNSYYWKEaGLN 629
Cdd:cd08662  456 ILQPPFF-DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPP-GLH 533
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 630 VKGKRTLAENIADNGGIRESFRAYRRWVEKErggvEEPLLPGVGLTHNQLFFLSYAHVRCNAYRPEAARDQIQSGAHSPP 709
Cdd:cd08662  534 VNGKLTLGENIADNGGLRLAYRAYKKWLKEN----GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPG 609
                        650       660
                 ....*....|....*....|....*..
gi 998614169 710 KYRVIGAMSNFEEFRKAFNCPETSIMN 736
Cdd:cd08662  610 KFRVNGPLSNSPEFAEAFNCPPGSPMN 636
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
72-736 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 748.43  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  72 VDPCDDFYQYACGGWLRENPIPEDSSSYGIYPWLRQNVDLKLKELLEQPVRSG-DIEAVKKAKVLYASCMNESALEIEDA 150
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAaDSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 151 NPLLKNLKQKEfRWPVLGDalgsssrwvesqfNLLETLAQIRSQHSKSVLIRLFVAPDDKNSNQYIIKLDQASLSLSSRE 230
Cdd:cd08662   81 KPLKPLLDKIG-GLPSLDD-------------LAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRD 146
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 231 DYitNTTEAQMYREALLRLMVDVSVMLGASEQAAEAQMKSVLDFEMKLAQIVIP-YENRTSENMYNKYSLSKLQRTVPDF 309
Cdd:cd08662  147 YY--LDEENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSsEELRDPEKTYNPLTLAELQKLAPSI 224
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 310 NWLGFVRAVIDTElypdlkiSSSEQVIVRAPQYFKDLFKLINATDTRTVANYVIWRSVFSRITTLSRRFLYRYLDFARVT 389
Cdd:cd08662  225 DWKAYLKALGPPA-------DDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKAL 297
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 390 TGTTSLTPRWDKCVNYVENTLIYAAGRLFVDKHFQEDKKHMMEELINGIRWAFIDILEkENEWMDEETKRKAIDKAHAVL 469
Cdd:cd08662  298 SGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLE-NLDWMDEETKKKALEKLDAMK 376
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 470 PKVGYPDFILNDTYINEDIKRLAFTmTDYFGNVMQTLKFIAQSDIGWLRKTVPRTEWFTNPTTVNAFYSSSTNQIRFPAG 549
Cdd:cd08662  377 VKIGYPDKWRDYSALDIYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAG 455
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 550 ELQKPFFwGLNYPRSLSYGAIGVIVGHELTHGFDNNGRKYDKDGNLDQWWSNSSINRFTEKTQCMIDQYNSYYWKEaGLN 629
Cdd:cd08662  456 ILQPPFF-DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPP-GLH 533
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 630 VKGKRTLAENIADNGGIRESFRAYRRWVEKErggvEEPLLPGVGLTHNQLFFLSYAHVRCNAYRPEAARDQIQSGAHSPP 709
Cdd:cd08662  534 VNGKLTLGENIADNGGLRLAYRAYKKWLKEN----GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPG 609
                        650       660
                 ....*....|....*....|....*..
gi 998614169 710 KYRVIGAMSNFEEFRKAFNCPETSIMN 736
Cdd:cd08662  610 KFRVNGPLSNSPEFAEAFNCPPGSPMN 636
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
59-745 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 562.08  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  59 EAAGSILSKMDQSVDPCDDFYQYACGGWLRENPIPEDSSSYGIYPWLRQNVDLKLKELLEQ----PVRSGDIEavKKAKV 134
Cdd:COG3590   24 GTSGIDLANMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEEaaaaPAAAGSDE--QKIGD 101
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 135 LYASCMNESALEIEDANPLLKNLKQKefrwpvlgDALGSSSrwvesqfNLLETLAQIRSQHSkSVLIRLFVAPDDKNSNQ 214
Cdd:COG3590  102 LYASFMDEAAIEALGLAPLKPDLARI--------DAIKDKA-------DLAALLAALHRAGV-GGLFGFGVDADLKNSTR 165
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 215 YIIKLDQASLSLSSREDYITNTTEAQMYREALLRLMVDVSVMLGASEQAAEAQMKSVLDFEMKLAQIVIP-YENRTSENM 293
Cdd:COG3590  166 YIAYLGQGGLGLPDRDYYLKDDEKSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSrVELRDPEKT 245
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 294 YNKYSLSKLQRTVPDFNWLGFVRAvidtelypdLKISSSEQVIVRAPQYFKDLFKLINATDTRTVANYVIWRSVFSRITT 373
Cdd:COG3590  246 YNPMTVAELAKLAPGFDWDAYLKA---------LGLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPY 316
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 374 LSRRFLYRYLDF-ARVTTGTTSLTPRWDKCVNYVENTLIYAAGRLFVDKHFQEDKKHMMEELINGIRWAFIDILEKeNEW 452
Cdd:COG3590  317 LSKAFVDANFDFyGKTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIEN-LDW 395
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 453 MDEETKRKAIDKAHAVLPKVGYPDfilndTYinEDIKRLAFTMTDYFGNVMQTLKFIAQSDIGWLRKTVPRTEWFTNPTT 532
Cdd:COG3590  396 MSPETKAKALEKLAAFTPKIGYPD-----KW--RDYSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEWGMTPQT 468
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 533 VNAFYSSSTNQIRFPAGELQKPFFwGLNYPRSLSYGAIGVIVGHELTHGFDNNGRKYDKDGNLDQWWSNSSINRFTEKTQ 612
Cdd:COG3590  469 VNAYYNPTMNEIVFPAAILQPPFF-DPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTK 547
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 613 CMIDQYNSYywkEA--GLNVKGKRTLAENIADNGGIRESFRAYRRWVEKERGGVEEpllpgvGLTHNQLFFLSYAHVRCN 690
Cdd:COG3590  548 KLVAQYDAY---EPlpGLHVNGKLTLGENIADLGGLSIAYDAYKLSLKGKEAPVID------GFTGDQRFFLGWAQVWRS 618
                        650       660       670       680       690
                 ....*....|....*....|....*....|....*....|....*....|....*.
gi 998614169 691 AYRPEAARDQIQSGAHSPPKYRVIGAMSNFEEFRKAFNCPETSIMNR-GAESCRVW 745
Cdd:COG3590  619 KARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMYLaPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
74-475 2.47e-137

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 409.77  E-value: 2.47e-137
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169   74 PCDDFYQYACGGWLRENPIPEDSSSYGIYPWLRQNVDLKLKELLEQPVRSG-DIEAVKKAKVLYASCMNESALEIEDANP 152
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAASEsDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  153 LLKNLKQkefrwpvLGDALGSSSRWvesqfNLLETLAQIRSqHSKSVLIRLFVAPDDKNSNQYIIKLDQASLSLSSREDY 232
Cdd:pfam05649  81 LKPLLDE-------IGGPLANKDKF-----DLLETLAKLRR-YGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYY 147
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  233 ITNTTEA-QMYREALLRLMVDVSVMLGASEQAAEAqMKSVLDFEMKLAQIVIPY-ENRTSENMYNKYSLSKLQRTVPDFN 310
Cdd:pfam05649 148 LKDRDEKsAEIREAYKAYIAKLLTLLGASEEAAAL-AEEVLAFETKLAKASLSReERRDPEKTYNPMTLAELQKLAPGID 226
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  311 WLGFVRAVIdtelypdLKISSSEQVIVRAPQYFKDLFKLINATDTRTVANYVIWRSVFSRITTLSRRFLYRYLDFARVTT 390
Cdd:pfam05649 227 WKAYLNAAG-------LPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTLS 299
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  391 GTTSLtPRWDKCVNYVENTLIYAAGRLFVDKHFQEDKKHMMEELINGIRWAFIDILEkENEWMDEETKRKAIDKAHAVLP 470
Cdd:pfam05649 300 GTKQR-PRWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLD-ELDWMDEETKKKALEKLDAMTV 377

                  ....*
gi 998614169  471 KVGYP 475
Cdd:pfam05649 378 KIGYP 382
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
72-736 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 748.43  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  72 VDPCDDFYQYACGGWLRENPIPEDSSSYGIYPWLRQNVDLKLKELLEQPVRSG-DIEAVKKAKVLYASCMNESALEIEDA 150
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAaDSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 151 NPLLKNLKQKEfRWPVLGDalgsssrwvesqfNLLETLAQIRSQHSKSVLIRLFVAPDDKNSNQYIIKLDQASLSLSSRE 230
Cdd:cd08662   81 KPLKPLLDKIG-GLPSLDD-------------LAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRD 146
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 231 DYitNTTEAQMYREALLRLMVDVSVMLGASEQAAEAQMKSVLDFEMKLAQIVIP-YENRTSENMYNKYSLSKLQRTVPDF 309
Cdd:cd08662  147 YY--LDEENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSsEELRDPEKTYNPLTLAELQKLAPSI 224
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 310 NWLGFVRAVIDTElypdlkiSSSEQVIVRAPQYFKDLFKLINATDTRTVANYVIWRSVFSRITTLSRRFLYRYLDFARVT 389
Cdd:cd08662  225 DWKAYLKALGPPA-------DDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKAL 297
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 390 TGTTSLTPRWDKCVNYVENTLIYAAGRLFVDKHFQEDKKHMMEELINGIRWAFIDILEkENEWMDEETKRKAIDKAHAVL 469
Cdd:cd08662  298 SGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLE-NLDWMDEETKKKALEKLDAMK 376
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 470 PKVGYPDFILNDTYINEDIKRLAFTmTDYFGNVMQTLKFIAQSDIGWLRKTVPRTEWFTNPTTVNAFYSSSTNQIRFPAG 549
Cdd:cd08662  377 VKIGYPDKWRDYSALDIYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAG 455
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 550 ELQKPFFwGLNYPRSLSYGAIGVIVGHELTHGFDNNGRKYDKDGNLDQWWSNSSINRFTEKTQCMIDQYNSYYWKEaGLN 629
Cdd:cd08662  456 ILQPPFF-DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPP-GLH 533
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 630 VKGKRTLAENIADNGGIRESFRAYRRWVEKErggvEEPLLPGVGLTHNQLFFLSYAHVRCNAYRPEAARDQIQSGAHSPP 709
Cdd:cd08662  534 VNGKLTLGENIADNGGLRLAYRAYKKWLKEN----GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPG 609
                        650       660
                 ....*....|....*....|....*..
gi 998614169 710 KYRVIGAMSNFEEFRKAFNCPETSIMN 736
Cdd:cd08662  610 KFRVNGPLSNSPEFAEAFNCPPGSPMN 636
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
59-745 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 562.08  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  59 EAAGSILSKMDQSVDPCDDFYQYACGGWLRENPIPEDSSSYGIYPWLRQNVDLKLKELLEQ----PVRSGDIEavKKAKV 134
Cdd:COG3590   24 GTSGIDLANMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEEaaaaPAAAGSDE--QKIGD 101
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 135 LYASCMNESALEIEDANPLLKNLKQKefrwpvlgDALGSSSrwvesqfNLLETLAQIRSQHSkSVLIRLFVAPDDKNSNQ 214
Cdd:COG3590  102 LYASFMDEAAIEALGLAPLKPDLARI--------DAIKDKA-------DLAALLAALHRAGV-GGLFGFGVDADLKNSTR 165
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 215 YIIKLDQASLSLSSREDYITNTTEAQMYREALLRLMVDVSVMLGASEQAAEAQMKSVLDFEMKLAQIVIP-YENRTSENM 293
Cdd:COG3590  166 YIAYLGQGGLGLPDRDYYLKDDEKSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSrVELRDPEKT 245
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 294 YNKYSLSKLQRTVPDFNWLGFVRAvidtelypdLKISSSEQVIVRAPQYFKDLFKLINATDTRTVANYVIWRSVFSRITT 373
Cdd:COG3590  246 YNPMTVAELAKLAPGFDWDAYLKA---------LGLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPY 316
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 374 LSRRFLYRYLDF-ARVTTGTTSLTPRWDKCVNYVENTLIYAAGRLFVDKHFQEDKKHMMEELINGIRWAFIDILEKeNEW 452
Cdd:COG3590  317 LSKAFVDANFDFyGKTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIEN-LDW 395
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 453 MDEETKRKAIDKAHAVLPKVGYPDfilndTYinEDIKRLAFTMTDYFGNVMQTLKFIAQSDIGWLRKTVPRTEWFTNPTT 532
Cdd:COG3590  396 MSPETKAKALEKLAAFTPKIGYPD-----KW--RDYSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEWGMTPQT 468
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 533 VNAFYSSSTNQIRFPAGELQKPFFwGLNYPRSLSYGAIGVIVGHELTHGFDNNGRKYDKDGNLDQWWSNSSINRFTEKTQ 612
Cdd:COG3590  469 VNAYYNPTMNEIVFPAAILQPPFF-DPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTK 547
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 613 CMIDQYNSYywkEA--GLNVKGKRTLAENIADNGGIRESFRAYRRWVEKERGGVEEpllpgvGLTHNQLFFLSYAHVRCN 690
Cdd:COG3590  548 KLVAQYDAY---EPlpGLHVNGKLTLGENIADLGGLSIAYDAYKLSLKGKEAPVID------GFTGDQRFFLGWAQVWRS 618
                        650       660       670       680       690
                 ....*....|....*....|....*....|....*....|....*....|....*.
gi 998614169 691 AYRPEAARDQIQSGAHSPPKYRVIGAMSNFEEFRKAFNCPETSIMNR-GAESCRVW 745
Cdd:COG3590  619 KARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMYLaPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
74-475 2.47e-137

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 409.77  E-value: 2.47e-137
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169   74 PCDDFYQYACGGWLRENPIPEDSSSYGIYPWLRQNVDLKLKELLEQPVRSG-DIEAVKKAKVLYASCMNESALEIEDANP 152
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAASEsDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  153 LLKNLKQkefrwpvLGDALGSSSRWvesqfNLLETLAQIRSqHSKSVLIRLFVAPDDKNSNQYIIKLDQASLSLSSREDY 232
Cdd:pfam05649  81 LKPLLDE-------IGGPLANKDKF-----DLLETLAKLRR-YGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYY 147
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  233 ITNTTEA-QMYREALLRLMVDVSVMLGASEQAAEAqMKSVLDFEMKLAQIVIPY-ENRTSENMYNKYSLSKLQRTVPDFN 310
Cdd:pfam05649 148 LKDRDEKsAEIREAYKAYIAKLLTLLGASEEAAAL-AEEVLAFETKLAKASLSReERRDPEKTYNPMTLAELQKLAPGID 226
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  311 WLGFVRAVIdtelypdLKISSSEQVIVRAPQYFKDLFKLINATDTRTVANYVIWRSVFSRITTLSRRFLYRYLDFARVTT 390
Cdd:pfam05649 227 WKAYLNAAG-------LPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTLS 299
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  391 GTTSLtPRWDKCVNYVENTLIYAAGRLFVDKHFQEDKKHMMEELINGIRWAFIDILEkENEWMDEETKRKAIDKAHAVLP 470
Cdd:pfam05649 300 GTKQR-PRWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLD-ELDWMDEETKKKALEKLDAMTV 377

                  ....*
gi 998614169  471 KVGYP 475
Cdd:pfam05649 378 KIGYP 382
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
534-744 2.47e-73

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 236.93  E-value: 2.47e-73
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  534 NAFYSSSTNQIRFPAGELQKPFFwGLNYPRSLSYGAIGVIVGHELTHGFDNNGRKYDKDGNLDQWWSNSSINRFTEKTQC 613
Cdd:pfam01431   1 NAYYQPNRNEIVFPAAILQPPFF-DPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQC 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169  614 MIDQYNSYYWKEAGLNVKGKRTLAENIADNGGIRESFRAYrrwveKERGGVEEPLLPGV-GLTHNQLFFLSYAHVRCNAY 692
Cdd:pfam01431  80 LIEQYSEYTPPDGTKCANGTLTLGENIADLGGLTIALRAY-----KKLLSANETVLPGFeNLTPDQLFFRGAAQIWCMKQ 154
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|..
gi 998614169  693 RPEAARDQIQSGAHSPPKYRVIGAMSNFEEFRKAFNCPETSIMNRgAESCRV 744
Cdd:pfam01431 155 SPAEVLRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNP-EPRCRL 205
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
495-604 4.44e-03

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 37.46  E-value: 4.44e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 998614169 495 MTDYFGNVMQTLKFiaqSDIGWLRKTVPRTEWFTNPTTVNAfYSSSTNQIRFPAGELQkpffwglnyprslSYGAIGVIV 574
Cdd:cd09594    7 TYKYYEELLGRTSF---RYPVSPIYSLLVYPAYVEVNAYNA-MWIPSTNIFYGAGILD-------------TLSGTIDVL 69
                         90       100       110
                 ....*....|....*....|....*....|
gi 998614169 575 GHELTHGFDNNGRKYDKdgNLDQWWSNSSI 604
Cdd:cd09594   70 AHELTHAFTGQFSNLMY--SWSSGWLNEGI 97
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH